Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
|Articles|February 1, 2006
- Volume 0 0
ADHD Can Disrupt Sleep
Advertisement
Insomnia is a common problem for children and adolescentswith attention-deficit/hyperactivity disorder (ADHD). Research hasshown that daytime drowsiness because of insufficient sleep canlead to learning and attention problems.
A new clinical trial, posted November 2005 on the www.clinicaltrials.gov Web site, is recruiting children and adolescents withADHD-related insomnia. The purpose of the study is to examinethe effects of a nonstimulating drug, atomoxetine—which is indicatedfor the treatment of ADHD—on ADHD-related insomnia. Amajority of drugs indicated for the treatment of ADHD symptomsin children and adults are stimulating and can aggravate sleepproblems. There is evidence that the trial's drug may improvesleep in children with ADHD.
Articles in this issue
almost 21 years ago
can you READ these Rxs?almost 21 years ago
Compounding HOTLINEalmost 21 years ago
A Quarter Century of Pharmacy Law—And the Fat Lady Is Singingalmost 21 years ago
It's Time for Education on Rx Drug Abusealmost 21 years ago
Improving Quality of Life for Psoriasis Patientsalmost 21 years ago
A Look at Diabetic Retinopathyalmost 21 years ago
The Graying of HIValmost 21 years ago
AutoCarouselalmost 21 years ago
Lexi-Comp Knowledge Solutionalmost 21 years ago
Refill TeleManagerAdvertisement
Related to this article
The costs to patients, their families, their workplaces, and their communities go well beyond dollars and cents.
Across every setting, the pharmacist's role is to build reliable systems around patients so stroke prevention remains safe and sustainable across the care continuum.
Pharmacists can plan career sabbaticals before retirement with smart savings, employer leave options, and intentional steps that balance their finances with their goals.
Like enzymes and coenzymes, monitoring devices and pharmacists may achieve more together than either can alone.
Every responsibility described in this issue depends on a pharmacy workforce with enough time and support to carry it.
Payer requirements, prescriber habits, and operational realities ultimately determine which ICI patients receive.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
2
FDA Requires Class-Wide GLP-1 RA Labeling Changes for Potential NAION Risk
3
Lilly–Hims & Hers GLP-1 Deal Tests Whether Convenience Can Deliver Continuity of Care
4
mRNA vs Protein-Based COVID-19 Vaccines: What Pharmacists Can Tell Patients
5